First author, year of publication, and reference
|
Assay method
|
Cut-off value
|
Cases, n
|
OS
|
PFSa
|
---|
| |
High expression
|
Low expression
|
HR (95% CI)
|
P
|
HR (95% CI)
|
P
|
---|
Lee 2013 [5]
|
qRT-PCR
|
Mean
|
NM
|
NM
|
0.84 (0.74 to 0.97) (M)b
|
0.017
|
NM
|
NM
|
Saija 2013 [6]
|
Microarray
|
Three-fold
|
215
|
53
|
0.67 (0.49 to 0.92) (U)b
|
<0.01
|
NM
|
NM
|
Campayo 2013 [7]
|
qRT-PCR
|
Mean
|
56
|
14
|
NM
|
NM
|
0.30 (0.12 to 0.73) (M)b
|
0.015
|
Yu 2013 [11]
|
qRT-PCR
|
Two-fold
|
125
|
125
|
0.21 (0.14 to 0.31) (U)b
|
<0.01
|
NM
|
NM
|
Avgeris 2013 [20]
|
qRT-PCR
|
Mean
|
35
|
27
|
NM
|
NM
|
0.79 (0.31 to 2.04) (M)
|
0.629
|
Tang 2013 [21]
|
qRT-PCR
|
Median
|
77
|
89
|
0.28 (0.11 to 0.91) (M)
|
0.010
|
0.24 (0.09 to 0.83) (M)
|
0.008
|
Tanaka 2013 [22]
|
qRT-PCR
|
Median
|
32
|
32
|
NM
|
NM
|
0.89 (0.38 to 2.09) (U)b
|
0.809
|
Speranza 2012 [23]
|
qRT-PCR
|
Median
|
8
|
7
|
0.23 (0.06 to 0.83) (U)b
|
0.018
|
NM
|
NM
|
Kang 2012 [24]
|
qRT-PCR
|
Median
|
NM
|
NM
|
NM
|
NM
|
0.68 (0.22 to 2.14) (U)
|
0.510
|
Schee 2012 [25]
|
qRT-PCR
|
Median
|
96
|
97
|
NM
|
NM
|
1.41 (0.76 to 2.59) (U)b
|
0.290
|
Law 2012 [9]
|
qRT-PCR
|
1.5-fold
|
15
|
32
|
NM
|
NM
|
0.22 (0.09 to 0.57) (U)b
|
<0.05
|
Ko 2012 [12]
|
qRT-PCR
|
Two-fold
|
13
|
12
|
NM
|
NM
|
2.56 (1.06 to 6.18) (U)b
|
0.037
|
Huang 2012 [26]
|
qRT-PCR
|
Mean
|
22
|
22
|
0.47 (0.17 to 1.33) (M)b
|
0.072
|
NM
|
NM
|
Marchini 2011 [27]
|
qRT-PCR
|
Median
|
NM
|
NM
|
0.14 (0.03 to 0.75) (M)
|
0.022
|
2.24 (0.47 to 10.59) (M)
|
0.309
|
Radojicic 2011 [28]
|
qRT-PCR
|
Mean
|
38
|
49
|
1.19 (0.58 to 2.45) (U)b
|
0.824
|
1.04 (0.52 to 2.09) (U)b
|
0.882
|
Leite 2011 [13]
|
qRT-PCR
|
Mean
|
NM
|
NM
|
NM
|
NM
|
3.35 (1.32 to 8.50) (M)
|
0.011
|
Hamano 2011 [29]
|
qRT-PCR
|
Median
|
49
|
49
|
0.58 (0.33 to 0.99) (U)b
|
0.023
|
NM
|
NM
|
Drebber 2011 [30]
|
qRT-PCR
|
Median
|
35
|
15
|
0.38 (0.11 to 1.31) (U)b
|
0.244
|
NM
|
NM
|
- CI, confidence interval; DFS, disease-free survival; HR, hazard ratio; M, multivariate analysis; MFS, metastasis-free survival; NM, not mentioned; OS, overall survival; PFS, progression-free survival; qRT-PCR, quantitative real-time PCR; RFS, relapse-free survival; U, univariate analysis.
- aPFS included any of the following: DFS, MFS or RFS.
- bHR and 95% CI calculated by survival curve.